Literature DB >> 29616290

Effect of ganaxolone in patients with posttraumatic stress disorder.

Tomoyuki Kawada1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29616290     DOI: 10.1007/s00213-018-4892-x

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  4 in total

1.  A randomized controlled trial of ganaxolone in posttraumatic stress disorder.

Authors:  Ann M Rasmusson; Christine E Marx; Sonia Jain; Gail M Farfel; Julia Tsai; Xiaoying Sun; Thomas D Geracioti; Mark B Hamner; James Lohr; Richard Rosse; Lanier Summerall; Jennifer C Naylor; Cristine Cusin; Ariel J Lang; Rema Raman; Murray B Stein
Journal:  Psychopharmacology (Berl)       Date:  2017-07-01       Impact factor: 4.530

Review 2.  Neuroactive steroids and PTSD treatment.

Authors:  Ann M Rasmusson; Christine E Marx; Suzanne L Pineles; Andrea Locci; Erica R Scioli-Salter; Yael I Nillni; Jennifer J Liang; Graziano Pinna
Journal:  Neurosci Lett       Date:  2017-02-12       Impact factor: 3.046

3.  Neuroactive Steroids and Affective Symptoms in Women Across the Weight Spectrum.

Authors:  Laura E Dichtel; Elizabeth A Lawson; Melanie Schorr; Erinne Meenaghan; Margaret Lederfine Paskal; Kamryn T Eddy; Graziano Pinna; Marianela Nelson; Ann M Rasmusson; Anne Klibanski; Karen K Miller
Journal:  Neuropsychopharmacology       Date:  2017-11-01       Impact factor: 7.853

Review 4.  Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis.

Authors:  Mathew Hoskins; Jennifer Pearce; Andrew Bethell; Liliya Dankova; Corrado Barbui; Wietse A Tol; Mark van Ommeren; Joop de Jong; Soraya Seedat; Hanhui Chen; Jonathan I Bisson
Journal:  Br J Psychiatry       Date:  2015-02       Impact factor: 9.319

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.